Virtual reality vision testing for people with retinal disease
Part of Eyes & vision, Genetic & congenital clinical trials.
This early-stage study uses virtual reality tasks to check how well a person can move and function using their eyesight. It may help researchers measure vision abilities in a way that could guide future care for retinal disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 5 years old (NEI site) or 13 years old (USyd site)
- You (or your parent/guardian) must understand the study and sign consent
- You must be able to cooperate with the virtual reality testing
- You must be able to read and speak English (or your guardian must, if you’re a minor)
- If you’re a healthy volunteer: you must have no retinal disease in either eye
- If you have retinal disease: you must have retinal disease in the study eye
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how your eyes use two types of light-sensing cells (rods for dim light and cones for clearer detail). It may help researchers better understand retinal (retina) diseases and how well vision is functioning.
This study tests a new virtual reality device to measure your field of vision (how well you see at the edges). It will compare the VR test to the standard bowl test. If you have healthy eyes or glaucoma, you may be able to join.
This study tests a quick, noninvasive eye test that measures how well you see in the dark, which can be an early sign of dry AMD. Researchers want to see if the test relates to everyday tasks like reading or driving at night.
This trial studies whether a virtual reality (VR) eye test can measure a child’s vision field (where they can see) instead of standard testing. It may help clinics test children in a more comfortable way, especially if traditional tests are hard for kids.
This study uses virtual reality tests to see if they can measure vision changes in people with age-related macular degeneration (AMD), a condition that affects central vision. It compares results from healthy volunteers and people at different stages of AMD.
This study is testing a virtual reality test to help people with low vision who are starting or have started rehabilitation. The goal is to see how well the test works for different types of vision loss.
Hear when a new Cone-Rod Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.